CFDE Data Portal | Search LINC02102

	Label	Description
	LINC02102 Gene (Entity type)	ENSG00000248677 - long intergenic non-protein coding RNA 2102
	GSE140441 temozolomide stem cell 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE217552 fisetin 3 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 14 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 8 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE126651 PRMT5 MTAP inhibition 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE181517 doxorubicin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE178267 vemurafenib 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 8 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE116133 GSE116136 H-7 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

LINC02102

ENSG00000248677 - long intergenic non-protein coding RNA 2102

GSE140441 temozolomide stem cell 2 v 0 human up

A Gene Set from LINCS

GSE217552 fisetin 3 v 4 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 14 v 6 human dn

A Gene Set from LINCS

GSE100148 EZH2 inhibition 8 v 5 human dn

A Gene Set from LINCS

GSE126651 PRMT5 MTAP inhibition 1 v 2 human up

A Gene Set from LINCS

GSE181517 doxorubicin 0 v 1 human up

A Gene Set from LINCS

GSE178267 vemurafenib 2 v 0 human up

A Gene Set from LINCS

GSE100148 EZH2 inhibition 8 v 7 human dn

A Gene Set from LINCS

GSE116133 GSE116136 H-7 1 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.